微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.08% | 2.86% | -40.98% | 46/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 1.83% | -37.11% | -17.57% | 45/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 2.22% | -36.02% | 42.31% | 47/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.56% | -46.02% | 48.57% | 45/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.05% | -23.91% | -63.92% | 48/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 2.91% | -7.32% | -16.14% | 49/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 3.47% | 8.44% | 20.07% | 50/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 2.89% | 7.04% | 109.42% | 49/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.38% | 4.55% | -56.05% | 53/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 3.14% | 19.39% | -1.88% | 47/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.2% | -27.77% | 18.52% | 51/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 2.7% | 49.17% | 104.55% | 46/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.32% | -8.33% | -49.81% | 47/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 2.63% | 209.41% | -40.63% | 52/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 4.43% | -35.89% | 144.75% | 49/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 1.81% | 50.83% | 25.69% | 56/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.44% | 87.01% | 69.41% | 51/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 0.85% | 302.38% | -87.7% | 59/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 6.91% | 39.88% | 475.83% | 33/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.2% | 6.19% | 55.84% | 55/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 0.77% | -14.44% | 283.33% | 53/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -0.42% | -112.07% | -108.5% | 58/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 4.94% | 19.9% | 337.17% | 43/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 1.13% | -60.76% | 25.56% | 58/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 0.9% | -44.44% | -74.14% | 57/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 3.48% | -27.8% | -15.53% | 52/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 4.12% | 4.57% | 43.06% | 48/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 2.88% | 8.68% | 77.78% | 47/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 1.62% | 55.77% | -66.39% | 44/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 4.82% | 8.8% | 22.34% | 52/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 3.94% | 9.44% | 48.68% | 52/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 2.65% | 12.77% | 154.81% | 52/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.04% | 38.67% | -76.52% | 48/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 4.43% | 28.78% | 23.06% | 55/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 3.6% | 15.38% | 53.19% | 47/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 2.35% | 2.17% | 213.33% | 50/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 0.75% | -11.76% | -78.2% | 51/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 3.44% | -2.55% | 10.26% | 55/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 3.12% | -19.79% | 35.65% | 47/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 2.3% | 94.92% | 170.59% | 46/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 0.85% | 10.39% | -75.92% | 45/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |